This shows LC/MS analysis of drugs in BSA with a gradient using polymer-based ODP2 HP. Each drug has peak areas between 98 - 107 % (peak areas without BSA are set as 100 %), which means a good separation without receiving ion suppression from protein.
Sample : drugs 500 ng/mL each in BSA (7.0 mg/L), 5 μL
Lidocaine
Chlorpheniramine
Propranolol
Diphenhydramine
Bupivacaine
Verapamil
Imipramine
Column : Shodex ODP2 HP-2B (2.0 mm I.D. x 50 mm) Eluent : (A);10 mM Ammonium acetate aq. (B);100 mM Ammonium acetate aq./CH3CN=10/90 gradient; (A) to (A) to 70 % (B) to 70 % (B) to (A), 0 min to 5 min to 10 min to 15 min to 15.01 min Flow rate : 0.2 mL/min Detector : ESI-MS (SIM Positive) Column temp. : 40 °C
Sample Name Index
Operation Manual / Certificate of Analysis
Operation Manuals and Certificate of Analysis / Inspection Certificate for the following products can be downloaded here.
Product Name Index
Applications
- Indomethacin in Serum (ODP-50 6E)
- Procainamide in Serum (ODP-50 4D)
- LC/MS Analysis of Barbital in BSA (ODP2 HP-2B)
- LC/MS Analysis of Drugs in BSA (1) (ODP2 HP)
- LC/MS/MS Analysis of Tricyclic Antidepressants in BSA (ODP2 HP)
- LC/MS Analysis of Drugs in Control Serum (ODP2 HP)
- Reproducibility in LC/MS Analysis (ODP2 HP)
- Influence of Proteins in LC/MS Analysis (ODP2 HP-2B)
- Direct Analysis of Acetaminophen in Serum (ODP2 HP)
- Direct Analysis of Risperidone in Urine (ODP2 HP)
- Simultaneous Analysis of Multi Symptom Cold Formula in Serum (ODP2 HP)
- Analysis of Anticonvulsant in Serum (ODP2 HP)
- Hippuric Acid etc. in Urine (2)